Clinical Trial Update: PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I first-in-human study of Hemay007 in healthy volunteers for inflammatory bowel disease, sponsored by Hemay Pharmaceutical PTY. LTD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Hemay007 (Hemay007)

Snippet

Sponsor: Hemay Pharmaceutical PTY. LTD. | Conditions: Inflammatory Bowel Disease | Phase 1 | Status: UNKNOWN